title: Impact of smokeless tobacco products on cardiovascular disease: implications for policy, prevention, and treatment: a policy statement from the American Heart Association.
authors.forename: Mariann R
authors.initials: MR
authors.lastname: Piano
authors.forename: Neal L
authors.initials: NL
authors.lastname: Benowitz
authors.forename: Garret A
authors.initials: GA
authors.lastname: Fitzgerald
authors.forename: Susan
authors.initials: S
authors.lastname: Corbridge
authors.forename: Janie
authors.initials: J
authors.lastname: Heath
authors.forename: Ellen
authors.initials: E
authors.lastname: Hahn
authors.forename: Terry F
authors.initials: TF
authors.lastname: Pechacek
authors.forename: George
authors.initials: G
authors.lastname: Howard
mesh_terms: D000572:American Heart Association; D002318:Cardiovascular Diseases / Q000453:epidemiology*; D006291:Health Policy; D006801:Humans; D009538:Nicotine / Q000009:adverse effects; D015995:Prevalence; D012307:Risk Factors; D012907:Smoking / Q000453:epidemiology / Q000628:therapy*; D016540:Smoking Cessation / Q000379:methods; D000074606:Smoking Prevention; D014030:Tobacco, Smokeless / Q000009:adverse effects* / Q000145:classification; D014481:United States / Q000453:epidemiology
chemical_list: D009538:Nicotine